ERBB2 and cancer: These results were verified in the METABRIC cohort, where both MYC v1 and v2 scores were elevated in higher American Joint Committee on Cancer (AJCC) cancer stage, higher grade, and TNBC or HER2-positive cancer (all p < 0.001).